Summary of Study ST002817
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001748. The data can be accessed directly via it's Project DOI: 10.21228/M8RQ7M This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002817 |
Study Title | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics |
Study Summary | We propose the use of targeted metabolomics to define the metabolic and molecular pathways altered in 2 mouse models (R92W-TnT and R403Q-MHC) of hypertrophic cardiomyopathy (HCM) that span the spectrum of human disease (heart failure and sudden death), with the goal of identifying treatment targets. Parallel targeted metabolomics studies will be performed in heart tissue and plasma at rest and following inotrope stimulation. Since energy compromise is expected to be most marked when the heart is subject to increased workload, as is the case during high-intensity exercise or inotropic stimulation, we propose metabolomics studies in heart tissue and plasma, at rest and following inotrope stimulation. We anticipate that the results of these studies will allow us to move forward with further investigations into specific metabolites of interest as biomarkers, to be tested in HCM patients in future studies. |
Institute | University of California, San Francisco |
Department | Hypertrophic Cardiomyopathy Center of Excellence |
Laboratory | UCSF Smith Cardiovascular Research Building |
Last Name | Abraham |
First Name | Maria Roselle |
Address | 555 Mission Bay Boulevard South, San Francisco, CA 94158 |
Roselle.Abraham@ucsf.edu | |
Phone | 415-502-3911 |
Submit Date | 2023-07-27 |
Num Groups | 2 groups of 2 (i.e., mutant vs control of two mouse models of HCM (R402Q-MyHC, R92W-TnT) |
Total Subjects | 32 |
Raw Data Available | Yes |
Raw Data File Type(s) | d |
Analysis Type Detail | LC-MS |
Release Date | 2023-09-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001748 |
Project DOI: | doi: 10.21228/M8RQ7M |
Project Title: | Investigation of metabolism in hypertrophic cardiomyopathy |
Project Summary: | We propose the use of targeted metabolomics to define the metabolic and molecular pathways altered in 2 mouse models (R92W-TnT and R403Q-MHC) of hypertrophic cardiomyopathy (HCM) that span the spectrum of human disease (heart failure and sudden death), with the goal of identifying treatment targets. Parallel targeted metabolomics studies will be performed in heart tissue and plasma at rest and following inotrope stimulation. Since energy compromise is expected to be most marked when the heart is subject to increased workload, as is the case during high-intensity exercise or inotropic stimulation, we propose metabolomics studies in heart tissue and plasma, at rest and following inotrope stimulation. We anticipate that the results of these studies will allow us to move forward with further investigations into specific metabolites of interest as biomarkers, to be tested in HCM patients in future studies. |
Institute: | University of California, San Francisco |
Department: | Hypertrophic Cardiomyopathy Center of Excellence |
Laboratory: | UCSF Smith Cardiovascular Research Building |
Last Name: | Abraham |
First Name: | Maria Roselle |
Address: | 555 Mission Bay Boulevard South, San Francisco, CA 94158 |
Email: | Roselle.Abraham@ucsf.edu |
Phone: | 415-502-3911 |
Contributors: | Arpana Vaniya (avaniya@ucdavis.edu), Anja Karlstaedt (Anja.Karlstaedt@cshs.org) |
Subject:
Subject ID: | SU002926 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA302586 | M503 | Control MHC |
SA302587 | M499 | Control MHC |
SA302588 | M447 | Control MHC |
SA302589 | M487 | Control MHC |
SA302590 | M492 | Control MHC |
SA302591 | M438 | Control MHC |
SA302592 | M440 | Control MHC |
SA302593 | M485 | Control MHC |
SA302594 | T545 | Control TNT |
SA302595 | T547 | Control TNT |
SA302596 | T544 | Control TNT |
SA302597 | T520 | Control TNT |
SA302598 | T515 | Control TNT |
SA302599 | T524 | Control TNT |
SA302600 | T518 | Control TNT |
SA302601 | T522 | Control TNT |
SA302610 | MtdBlank004 | Method Blank |
SA302611 | MtdBlank002 | Method Blank |
SA302612 | MtdBlank005 | Method Blank |
SA302613 | MtdBlank003 | Method Blank |
SA302614 | MtdBlank007 | Method Blank |
SA302615 | MtdBlank001 | Method Blank |
SA302616 | MtdBlank008 | Method Blank |
SA302617 | MtdBlank006 | Method Blank |
SA302602 | M540 | MHC |
SA302603 | M498 | MHC |
SA302604 | M486 | MHC |
SA302605 | M439 | MHC |
SA302606 | M483 | MHC |
SA302607 | M500 | MHC |
SA302608 | M441 | MHC |
SA302609 | M504 | MHC |
SA302618 | Pool001 | Pool QC |
SA302619 | Pool002 | Pool QC |
SA302620 | Pool004 | Pool QC |
SA302621 | Pool003 | Pool QC |
SA302622 | Pool005 | Pool QC |
SA302623 | Pool006 | Pool QC |
SA302624 | Pool008 | Pool QC |
SA302625 | Pool007 | Pool QC |
SA302626 | Biorec001 | QC |
SA302627 | Biorec002 | QC |
SA302628 | Biorec006 | QC |
SA302629 | Biorec005 | QC |
SA302630 | Biorec007 | QC |
SA302631 | Biorec008 | QC |
SA302632 | Biorec003 | QC |
SA302633 | Biorec004 | QC |
SA302634 | T527 | TNT |
SA302635 | T521 | TNT |
SA302636 | T519 | TNT |
SA302637 | T523 | TNT |
SA302638 | T525 | TNT |
SA302639 | T542 | TNT |
SA302640 | T540 | TNT |
SA302641 | T546 | TNT |
Showing results 1 to 56 of 56 |
Collection:
Collection ID: | CO002919 |
Collection Summary: | Excision while the heart still beating and flash freeze within 15 seconds of excision |
Sample Type: | Heart |
Treatment:
Treatment ID: | TR002935 |
Treatment Summary: | Saline IP and heparine SC injection in control & mutant group. After 10 minutes of saline injection we performed cervical dislocation, whole heart excision and flash freeze within 15 seconds of excision. |
Sample Preparation:
Sampleprep ID: | SP002932 |
Sampleprep Summary: | 2 mg of lyophilized tissue extracted with 225 uL MeOH + 188 uL H2O + 750 uL MTBE. 350 uL of the organic layer was dried and resuspended 90:10 MeOH + Toluene with internal standards. |
Combined analysis:
Analysis ID | AN004584 | AN004585 | AN004586 |
---|---|---|---|
Analysis type | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | Reversed phase |
Chromatography system | Agilent 1290 | Agilent 1290 | Waters Acquity |
Column | Waters ACQUITY UPLC CSH C18 (100 x 1mm,1.7um) | Waters ACQUITY UPLC CSH C18 (100 x 1mm,1.7um) | Waters ACQUITY UPLC BEH C18 (100 x 2.1mm,1.7um) |
MS Type | ESI | ESI | ESI |
MS instrument type | QTOF | QTOF | Orbitrap |
MS instrument name | Agilent 6530 QTOF | Agilent 6550 QTOF | Thermo Q Exactive Orbitrap |
Ion Mode | POSITIVE | NEGATIVE | POSITIVE |
Units | peak heights | peak heights | raw area counts rescaled to set the median equal to 1 |
Chromatography:
Chromatography ID: | CH003445 |
Chromatography Summary: | - |
Instrument Name: | Agilent 1290 |
Column Name: | Waters ACQUITY UPLC CSH C18 (100 x 1mm,1.7um) |
Column Temperature: | 65C |
Flow Gradient: | 0 min 15% (B), 0–2 min 30% (B), 2–2.5 min 48% (B), 2.5–11 min 82% (B), 11–11.5 min 99% (B), 11.5– 12 min 99% (B), 12–12.1 min 15% (B), 12.1–15 min 15% (B) |
Flow Rate: | 0.6 mL/min |
Solvent A: | 60:40 v/v acetonitrile:water + 10 mM ammonium formate + 0.1% formic acid |
Solvent B: | 90:10 v/v isopropanol:acetonitrile + 10 mM ammonium formate + 0.1% formic acid |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH003446 |
Chromatography Summary: | Low pH polar (LC/MS Pos early) |
Instrument Name: | Waters Acquity |
Column Name: | Waters ACQUITY UPLC BEH C18 (100 x 2.1mm,1.7um) |
Column Temperature: | - |
Flow Gradient: | - |
Flow Rate: | - |
Solvent A: | - |
Solvent B: | - |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS004330 |
Analysis ID: | AN004584 |
Instrument Name: | Agilent 6530 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | The quadrupole/time-of-flight (QTOF) mass spectrometers are operated with electrospray ionization (ESI) performing full scan in the mass range m/z 65–1700 in positive (Agilent 6530, equipped with a JetStreamSource) and negative (Agilent 6550, equipped with a dual JetStream Source) modes producing both unique and complementary spectra. Instrument parameters are as follows (positive mode) Gas Temp 325°C, Gas Flow 8 l/min, Nebulizer 35 psig, Sheath Gas 350°C, Sheath Gas Flow 11, Capillary Voltage 3500 V, Nozzle Voltage 1000V, Fragmentor 120V, Skimmer 65V. Data (both profile and centroid) are collected at a rate of 2 scans per second. In negative ion mode, Gas Temp 200°C, Gas Flow 14 l/min, Fragmentor 175V, with the other parameters identical to positive ion mode. For the 6530 QTOF, a reference solution generating ions of 121.050 and 922.007 m/z in positive mode and 119.036 and 966.0007 m/z in negative mode, and these are used for continuous mass correction. For the 6550, the reference solution is introduced via a dual spray ESI, with the same ions and continuous mass correction |
Ion Mode: | POSITIVE |
MS ID: | MS004331 |
Analysis ID: | AN004585 |
Instrument Name: | Agilent 6550 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | The quadrupole/time-of-flight (QTOF) mass spectrometers are operated with electrospray ionization (ESI) performing full scan in the mass range m/z 65–1700 in positive (Agilent 6530, equipped with a JetStreamSource) and negative (Agilent 6550, equipped with a dual JetStream Source) modes producing both unique and complementary spectra. Instrument parameters are as follows (positive mode) Gas Temp 325°C, Gas Flow 8 l/min, Nebulizer 35 psig, Sheath Gas 350°C, Sheath Gas Flow 11, Capillary Voltage 3500 V, Nozzle Voltage 1000V, Fragmentor 120V, Skimmer 65V. Data (both profile and centroid) are collected at a rate of 2 scans per second. In negative ion mode, Gas Temp 200°C, Gas Flow 14 l/min, Fragmentor 175V, with the other parameters identical to positive ion mode. For the 6530 QTOF, a reference solution generating ions of 121.050 and 922.007 m/z in positive mode and 119.036 and 966.0007 m/z in negative mode, and these are used for continuous mass correction. For the 6550, the reference solution is introduced via a dual spray ESI, with the same ions and continuous mass correction |
Ion Mode: | NEGATIVE |
MS ID: | MS004332 |
Analysis ID: | AN004586 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Metabolon (LC/MS Pos early) |
Ion Mode: | POSITIVE |